MHRA Drug Safety Update for May 2022
MHRA Drug Safety Update May 2022
Posted: Monday, May 23, 2022
Category - Medicines Update
Medicines Update
GGC Medicines Update is a series of blogs with important medicines related messages relevant to all healthcare professionals across GGC.
- Subscribe to our blog via email:ggc.medicines.update@nhs.scot
- Follow us on Twitter
Please note, Medicines Update blogs are correct at the time of publication.
Medicines Update blogs remain on the website for 4 years. If you would like a copy of a blog published more than 4 years ago, please contact ggc.medicines.update@nhs.scot.
Click here for a promotional poster on Medicines Update and here for an animation on the Communications subcommittee of ADTC responsible for the development of Medicines Update.
If you would like to contribute to Medicines Update, click here for further information and here for a guide to blog writing. When you email the committee to discuss writing a blog, you will be sent a checklist to complete prior to submitting the blog for review.
HEPMA Top Tips Update
Posted: Tuesday, May 17, 2022
Category - Medicines Update
Realistic Medicine - Chronic Non-Malignant Pain Management
Posted: Friday, May 13, 2022
Category - Medicines Update
An approach based on the mnemonic ‘SUGAR’ has been developed for use in pain reviews.
Key Medicine Shortages – May 2022
Posted: Friday, May 6, 2022
Category - Medicines Update
Key Medicine Shortages for May 2022
Guideline News April 2022
Posted: Friday, May 6, 2022
Category - Medicines Update
Guideline News for April 2022
Management of Generalised Convulsive Status Epilepticus in Adults Guideline - Update
Posted: Friday, April 29, 2022
Category - Medicines Update
The NHSGGC management of generalised convulsive status epilepticus in adults guideline has been updated.
Key changes
- Benzodiazepine options, doses and routes of administration for initial treatment have been updated
- Three antiepileptic drugs (AEDs) are now included as treatment options when seizures persist following benzodiazepines:- Levetiracetam, sodium valproate and phenytoin
- Details of indications, cautions and considerations are included to help guide choice of treatment
Yellow Card Reporting – An update for healthcare professionals
Posted: Wednesday, April 27, 2022
Category - Medicines Update
All healthcare professionals involved in patient care have a responsibility to report suspected ADRs
Opioid Safety - Key safety tips
Posted: Friday, April 22, 2022
Category - Medicines Update
Opioid choice
Patient factors
Indication
Observe
Independent check
Dose equivalence
Storage
MHRA Drug Safety Update April 2022
Posted: Wednesday, April 20, 2022
Category - Medicines Update
MHRA Drug Safety Update for April 2022
Safe Use of Lithium
Posted: Friday, April 15, 2022
Category - Medicines Update
Key messages: Lithium is a gold standard treatment for maintenance treatment of bipolar affective disorder Lithium has a high potential for toxicity and requires careful monitoring to ensure its safe and...